Status:

NOT_YET_RECRUITING

Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital

Lead Sponsor:

Assiut University

Conditions:

NAFLD - Nonalcoholic Fatty Liver Disease

Eligibility:

All Genders

18-75 years

Brief Summary

Aim of the study :- 1. to estimate prevalence of non alcoholic fatty liver disease and liver fibrosis among Systemic lupus erythematosus patients 2. to determine risk factors in SLE patients contribu...

Detailed Description

Lupus Erythematosus (SLE) is a systemic, multi organ, Autoimmune disease that more common in women than men and is typically diagnosed during the reproductive age .1 Lupus affects almost all organs an...

Eligibility Criteria

Inclusion

  • Adult patients aged 18 years old ,Both sex male and female, diagnosed with SLE

Exclusion

  • Age below 18 years old
  • patients with hepatitis b virus (HBV), hepatitis c virus (HCV) or cirrhosis
  • malignancy, cardiac disease,
  • patients on dialysis.
  • obese patient, BMI more than 30

Key Trial Info

Start Date :

October 1 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

112 Patients enrolled

Trial Details

Trial ID

NCT06601361

Start Date

October 1 2024

End Date

December 1 2025

Last Update

September 19 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital | DecenTrialz